Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case–control study
暂无分享,去创建一个
L. Giordano | F. Mannelli | G. Perilongo | R. Riccardi | U. Raucci | C. Romagnoli | A. Chiaretti | I. Raffaldi | L. Sagliocca | E. Chiappini | F. Trotta | A. Capuano | N. Mores | M. Martino | N. Pirozzi | F. Ferrazin | S. Sollai | C. Fancelli | P. Tovo | C. Santuccio | L. Dalt | A. Calvani | G. Traversa | V. Tipo | F. Menniti‐Ippolito | C. Rafaniello | A. Reale | E. Venturini | A. Urbino | M. Baraldi | S. Renna | G. Bersani | C. Gabiano | R. Cas | F. Fucà | A. Nisco | L. Tartaglia | R. Rossi | M. Dinardo | P. Pietro | C. Calitri | F. Bertuola | R. Mazzantini | V. Favero | Bianca Domenichini | Stefania Gamba | F. Trovato | M. Bianciotto | Eleonora Lorenzon | Francesca Parata | S. Vendramin | M. Frassineti | Teresa Pisapia | Eleonora Di Rosa | Elisabetta Parretta
[1] Weizhong Yang,et al. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. , 2011, The New England journal of medicine.
[2] M. Valenciano,et al. Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study , 2011, PLoS medicine.
[3] Alberto Arnedo-Pena,et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. , 2010, Vaccine.
[4] F. Polack,et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. , 2010, The New England journal of medicine.
[5] S. Black,et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines , 2009, The Lancet.
[6] S. Lapinsky,et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. , 2009, JAMA.
[7] B. Psaty,et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. , 2006, International journal of epidemiology.
[8] A. Schattner. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. , 2005, Vaccine.
[9] F. Vetrano,et al. Extrapyramidal reactions in children treated with metoclopramide , 2004 .
[10] A. Hoes,et al. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications , 2002, Journal of epidemiology and community health.
[11] L. Sagliocca,et al. Niflumic acid and cutaneous reactions in children , 2001, Archives of disease in childhood.
[12] X. Mu. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. , 2011, The New England journal of medicine.
[13] Tom Jefferson,et al. Vaccines for preventing influenza in the elderly. , 2010, The Cochrane database of systematic reviews.
[14] G. Perilongo,et al. Association between Drug and Vaccine Use and Acute Immune Thrombocytopenia in Childhood , 2010, Drug safety.